Section 301 tariffs are seen as more legally sound and flexible than other powers Trump has eyed, but also more time-consuming. 

China’s biotech sector is booming, but its growth has coincided with backlash from the U.S.

India is the first market where Novo Nordisk faces generic competition for semaglutide — the active ingredient in Ozempic and Wegovy.

Oral GLP-1s are set to shake up the weight-loss drug market, but industry onlookers will be wondering how these new tablets might impact healthcare supply chains.

Tecsys's new pharmacy survey unveils a serious lack of supply chain visibility in an industry that needs it more than ever. Guy Courtin, vice president industry and global alliances, explains.

Join us for this engaging webinar as we explore the fundamentals of Human-Machine collaboration in supply chain planning. We’ll discuss strategic considerations, practical approaches, and emerging best practices to help you unlock greater value, enhance decision-making, and build more adaptive and resilient planning processes.

Modern shippers face growing complexity in managing transportation spend, yet the RFP processes used to evaluate freight audit and payment (FAP) providers remain largely outdated.

The TCA called for the passage of a bill that would require positive hair test results be included in the federal clearinghouse.  

Takaichi announced the initiative at a regional forum that included Japan and major Southeast Asian economies such as Thailand, Vietnam, the Philippines and Malaysia.

The fragrance industry, once dominated by alcohol-based sprays packaged in glass bottles, is expanding to include oils, balms, solids, aerosols and other alternative formats that fall under hazmat regulations.